Company registration number 02659543 (England and Wales)
CRYOGENIC LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
CRYOGENIC LIMITED
COMPANY INFORMATION
Directors
Dr J Good
Dr R Mitchell
Ms Z Omar
Mr M Owczarkowski
Secretary
Mr N Krishnathas
Company number
02659543
Registered office
Unit 6, Acton Park Industrial Estate
The Vale
Acton
London
W3 7QE
Auditor
Ward Williams Limited
Belgrave House
39-43 Monument Hill
Weybridge
Surrey
KT13 8RN
Bankers
National Westminster Bank Plc
Turnpike House
123 High Street
Crawley
West Sussex
RH10 1DQ
Santander UK plc
Bridle Road, Bootle
Merseyside
L30 4GB
CRYOGENIC LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3
Directors' responsibilities statement
4
Independent auditor's report
5 - 7
Income statement
8
Statement of comprehensive income
9
Statement of financial position
10
Statement of changes in equity
11
Statement of cash flows
12
Notes to the financial statements
13 - 28
CRYOGENIC LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 1 -
The directors present the strategic report and financial statements for the year ended 31 March 2025.
Review of the business
The principal activity of the company continues to be the design and manufacture of superconducting magnets, cryogenic machines and instruments. Of particular interest and value are the powerful magnets needed for gyrotrons, which are an essential part of fusion reactors, which are the preferred solution to the energy crisis and climate change. Other magnets are used for research in physics and materials science, nuclear magnetic resonance and imaging.
The results for the business are set out on page 8. The company has performed in line with expectations, notwithstanding the impact of increased inflation in the UK. The directors are satisfied with the year-end position and remain confident in the company's future prospects.
Key Performance Indicators
The directors use and review many performance measures. Three key performance indicators required for the company to meet its objectives are:
2025 2024
Revenue £15.84m £15.39m
Gross Profit £9.78m £9.11m
Gross Profit margin 61.7% 59.2%
The directors consider the track of these KPIs indicate that the company is achieving its business objectives.
CRYOGENIC LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
Principal risks and uncertainties
Financial risk management
The company uses various financial instruments including bank loans, hire purchase contracts, cash and various items such as trade creditors that arise directly from its operations. The main purpose for these financial instruments is to finance the company's operations. The principal risks arising from the company's financial instruments are liquidity risk, currency risk, credit risk and cash flow interest rate risk. The directors review and agree policies for managing each of these risks and they are summarised below:
Liquidity risk
The company is funded by retained earnings and loans. Its funding requirements are reviewed regularly by the directors and the finance department of Cryogenic Ltd to ensure the company has sufficient funds for operations and expansion. Hire purchase contracts are established to match the turnover and life of the assets. The maturity of borrowings is set out in note 17 to the accounts.
Currency risk
The company enters into forward contracts throughout the year to mitigate the risk of adverse currency fluctuations.
Credit risk
Trade debtors are managed in respect of credit and cash flow risk by policies concerning the credit offered to customers and the regular monitoring of amounts outstanding for both time and credit limits. Trade creditors liquidity risk is managed by ensuring sufficient funds are available to meet amounts due.
Cash flow interest rate risk
The directors have considered the interest rate risk and concluded that the company is not exposed to a significant level of interest risk and consequently no risk management tools have been used.
Environmental
The company believes it is in the company's best interest to minimise the risk arising from the social and environmental impact of its activities and is committed to conducting its activities and operations in line with current legislation and best environmental practice.
Research and development
Activities are concentrated on ensuring that Cryogenic continue to compete in the market with emphasis on a new product pipeline that is considered by the directors to be of key importance to the business strategy for growth.
Dr J Good
Director
4 December 2025
CRYOGENIC LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
The directors present their annual report and financial statements for the year ended 31 March 2025.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Dr J Good
Dr R Mitchell
Ms Z Omar
Mr M Owczarkowski
Secretary
Nishanthan Krishnathas has been appointed company secretary.
Results and dividends
The results for the year are set out on page 8.
The directors do not recommend payment of an ordinary dividend.
Auditor
The auditors, Ward Williams Limited, are deemed to be reappointed under section 487(2) of the Companies Act 2006.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
On behalf of the board
Dr J Good
Director
4 December 2025
CRYOGENIC LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
CRYOGENIC LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF CRYOGENIC LIMITED
- 5 -
Opinion
We have audited the financial statements of Cryogenic Limited (the 'company') for the year ended 31 March 2025 which comprise the income statement, the statement of comprehensive income, the statement of financial position, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The directors are responsible for the other information. The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
CRYOGENIC LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CRYOGENIC LIMITED
- 6 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
The objectives of our audit are to identify and assess the risks of material misstatement of the financial statements due to fraud or error; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud or error; and to respond appropriately to those risks. Owing to the inherent limitations of an audit, there is an unavoidable risk that material misstatements in the financial statements may not be detected, even though the audit is properly planned and performed in accordance with the ISAs (UK).
In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our procedures included the following:
CRYOGENIC LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CRYOGENIC LIMITED
- 7 -
identifying and assessing the design effectiveness of controls management has in place to prevent and detect fraud;
understanding how those charged with governance considered and addressed the potential for override of controls or other inappropriate influence over the financial reporting process;
challenging assumptions and judgements made by management in its significant accounting estimates;
identifying and testing journal entries, in particular and journal entries posted with unusual account combinations; and
assessing the extent of compliance with the relevant laws and regulations.
Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Colin Hamilton (Senior Statutory Auditor)
for and on behalf of Ward Williams Limited
4 December 2025
Chartered Accountants
Belgrave House
Statutory Auditor
39-43 Monument Hill
Weybridge
Surrey
KT13 8RN
CRYOGENIC LIMITED
INCOME STATEMENT
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
2025
2024
Notes
£
£
Revenue
3
15,840,437
15,393,532
Cost of sales
(6,061,308)
(6,283,030)
Gross profit
9,779,129
9,110,502
Administrative expenses
(8,395,491)
(7,662,186)
Operating profit
4
1,383,638
1,448,316
Finance costs
7
(250,493)
(293,271)
Other gains and losses
8
38,974
41,776
Profit before taxation
1,172,119
1,196,821
Tax on profit
9
131,821
99,381
Profit for the financial year
1,303,940
1,296,202
The income statement has been prepared on the basis that all operations are continuing operations.
CRYOGENIC LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2025
- 9 -
2025
2024
£
£
Profit for the year
1,303,940
1,296,202
Other comprehensive income
-
-
Total comprehensive income for the year
1,303,940
1,296,202
CRYOGENIC LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 MARCH 2025
31 March 2025
- 10 -
2025
2024
as restated
Notes
£
£
£
£
Non-current assets
Intangible assets
10
26,812
22,741
Property, plant and equipment
11
1,050,868
1,116,769
1,077,680
1,139,510
Current assets
Inventories
13
3,658,549
4,915,083
Trade and other receivables
14
14,480,861
12,235,976
Cash and cash equivalents
101,425
626,263
18,240,835
17,777,322
Current liabilities
15
(7,035,590)
(7,526,191)
Net current assets
11,205,245
10,251,131
Total assets less current liabilities
12,282,925
11,390,641
Non-current liabilities
16
(441,791)
(853,447)
Net assets
11,841,134
10,537,194
Equity
Called up share capital
20
31,600
31,600
Share premium account
21
53,400
53,400
Retained earnings
22
11,756,134
10,452,194
Total equity
11,841,134
10,537,194
The financial statements were approved by the board of directors and authorised for issue on 4 December 2025 and are signed on its behalf by:
Dr J Good
Director
Company Registration No. 02659543
CRYOGENIC LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
- 11 -
Share capital
Share premium account
Retained earnings
Total
£
£
£
£
Balance at 1 April 2023
31,600
53,400
9,155,992
9,240,992
Year ended 31 March 2024:
Profit and total comprehensive income
-
-
1,296,202
1,296,202
Balance at 31 March 2024
31,600
53,400
10,452,194
10,537,194
Year ended 31 March 2025:
Profit and total comprehensive income
-
-
1,303,940
1,303,940
Balance at 31 March 2025
31,600
53,400
11,756,134
11,841,134
CRYOGENIC LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2025
- 12 -
2025
2024
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from/(absorbed by) operations
28
397,139
(186,057)
Interest paid
(250,493)
(293,271)
Income taxes refunded
99,381
284,548
Net cash inflow/(outflow) from operating activities
246,027
(194,780)
Investing activities
Purchase of intangible assets
(6,711)
(22,741)
Purchase of property, plant and equipment
(202,770)
(246,790)
Proceeds from disposal of investments
38,974
41,776
Net cash used in investing activities
(170,507)
(227,755)
Financing activities
Repayment of bank loans
(516,646)
(65,850)
Repayment of derivatives
30,271
(96,714)
Payment of finance leases obligations
(113,983)
(173,470)
Net cash used in financing activities
(600,358)
(336,034)
Net decrease in cash and cash equivalents
(524,838)
(758,569)
Cash and cash equivalents at beginning of year
626,263
1,384,832
Cash and cash equivalents at end of year
101,425
626,263
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 13 -
1
Accounting policies
Company information
Cryogenic Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 6, Acton Park Industrial Estate, The Vale, Acton, London, W3 7QE.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest pound.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
The company meets its day to day working capital requirements through an overdraft facility, bank loans, and a loan from a director / shareholder. The nature of the business is such that there can be an element of inconsistency in the timing of cash inflows. However, the directors have prepared detailed forecasts and based on these, correspondence with the bank and continued support of the director / shareholder, consider that the company will have sufficient working capital and will be able to operate within the terms of the current facilities for at least the next 12 months.
1.3
Revenue
Revenue is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Profit is recognised on long term contracts if the final outcome can be assessed with reasonable certainty, by recognising in the income statement revenue and related cost as contract activity progresses. Revenue is calculated as that proportion of total contract value which cost to date bear to total expected cost for that contract.
1.4
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Patents
10 years
Development Costs
4 years
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 14 -
1.5
Property, plant and equipment
Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Land and buildings Short leasehold
Straight line over the life of the lease
Plant and machinery
20% reducing balance & 10% straight line
Fixtures, fittings & equipment
20% reducing balance & 33% reducing balance
Computer equipment
33% reducing balance
Motor vehicles
33% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.6
Impairment of non-current assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Intangible assets with indefinite useful lives and intangible assets not yet available for use are tested for impairment annually, and whenever there is an indication that the asset may be impaired.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) prior years. A reversal of an impairment loss is recognised immediately in profit or loss.
1.7
Inventories
Inventories are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition.
Inventories held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of inventories over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 15 -
1.8
Long term contracts
Where the outcome of a long term contract can be estimated reliably, revenue and costs are recognised by reference to the stage of completion of the contract activity at the reporting end date. Variations in contract work, claims and incentive payments are included to the extent that the amount can be measured reliably and its receipt is considered probable.
When it is probable that total contract costs will exceed total contract revenue, the expected loss is recognised as an expense immediately.
Where the outcome of a long term contract cannot be estimated reliably, contract costs are recognised as expenses in the period in which they are incurred and contract revenue is recognised to the extent of contract costs incurred where it is probable that they will be recoverable.
The “percentage of completion method” is used to determine the appropriate amount to recognise in a given period. The stage of completion is measured by the proportion of contract costs incurred for work performed to date compared to the estimated total contract costs. Costs incurred in the year in connection with future activity on a contract are excluded from contract costs in determining the stage of completion. These costs are presented as stocks, prepayments or other assets depending on their nature, and provided it is probable they will be recovered.
Amounts recoverable on long term contracts, which are included in receivables, are stated at the net sales value of the work done after provision for contingencies and anticipated future losses on contracts, less amounts received as progress payments on account. Excess progress payments are included in creditors as payments on account.
1.9
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.10
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 16 -
Trade receivables, loans and other receivables that have fixed or determinable payments that are not quoted in an active market are classified as 'loans and receivables'. Loans and receivables are measured at amortised cost using the effective interest method, less any impairment.
Interest is recognised by applying the effective interest rate, except for short-term receivables when the recognition of interest would be immaterial. The effective interest method is a method of calculating the amortised cost of a debt instrument and of allocating the interest income over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash receipts through the expected life of the debt instrument to the net carrying amount on initial recognition.
Impairment of financial assets
Financial assets, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired the impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including trade and other payables and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Other financial liabilities
Derivatives, including forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 17 -
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.11
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.12
Derivatives
Derivatives are initially recognised at fair value at the date a derivative contract is entered into and are subsequently remeasured to fair value at each reporting end date. The resulting gain or loss is recognised in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship.
A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.
1.13
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.14
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of inventory.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 18 -
1.15
Retirement benefits
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are charged to the income statement in the year they are payable.
1.16
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the statement of financial position as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.
1.17
Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.
1.18
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in the income statement for the period.
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 19 -
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Critical judgements
The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.
Useful lives of plant and equipment
In determining appropriate depreciation rates to apply against property, plant and equipment, the directors have used their knowledge and experience of both the company and the industry to assess the useful lives of each individual asset.
Provision for the impairment of receivables
The company establishes a provision for the impairment of trade receivables in accordance with its policy in note 1. The recoverable amount of trade receivables is compared to the carrying amount to determine the amount of impairment. These calculations require the use of estimates.
Stage of completion of long term contracts
The company have long term contracts in place, and recognise revenue and costs based on the stage of completion of these contracts, as set out in note 1. The stage of completion of contracts is based on the directors' judgement.
3
Revenue
An analysis of the company's revenue is as follows:
2025
2024
£
£
Turnover
Sale of goods
15,840,437
15,393,532
Revenue analysed by geographical market
2025
2024
£
£
United Kingdom
1,528,889
470,151
EEC
2,369,640
3,085,257
Other
11,941,908
11,838,125
15,840,437
15,393,532
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 20 -
4
Operating profit
2025
2024
Operating profit for the year is stated after charging/(crediting):
£
£
Exchange gains
(103,365)
(423,487)
Fees payable to the company's auditor for the audit of the company's financial statements
18,000
15,800
Depreciation of owned property, plant and equipment
50,413
112,165
Depreciation of property, plant and equipment held under finance leases
218,258
277,375
Amortisation of intangible assets
2,640
-
Cost of inventories recognised as an expense
5,612,124
5,829,797
Operating lease charges
826,469
644,509
5
Directors' remuneration
2025
2024
£
£
Remuneration for qualifying services
490,306
480,831
Company pension contributions to defined contribution schemes
93,765
67,038
584,071
547,869
The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 3 (2024 - 3).
Remuneration disclosed above include the following amounts paid to the highest paid director:
2025
2024
£
£
Remuneration for qualifying services
182,780
137,672
6
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Administration
10
11
Sales and distribution
7
8
Production
84
80
Total
101
99
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
6
Employees
(Continued)
- 21 -
2025
2024
£
£
Wages and salaries
5,137,080
4,881,209
Social security costs
564,468
531,977
Pension costs
596,336
505,885
6,297,884
5,919,071
7
Finance costs
2025
2024
£
£
Interest on financial liabilities measured at amortised cost:
Interest on bank overdrafts and loans
(4,085)
(1,249)
Other finance costs:
Interest on finance leases and hire purchase contracts
254,578
294,520
250,493
293,271
8
Other gains and losses
2025
2024
£
£
Fair value gains/(losses) on financial instruments
Exchange differences arising on hedging instrument in cash flow hedge
38,974
41,776
9
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
(131,821)
(99,381)
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
9
Taxation
(Continued)
- 22 -
The actual credit for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit before taxation
1,172,119
1,196,821
Expected tax charge based on the standard rate of corporation tax in the UK of 0% (2024: 0%)
Research and development tax credit
(131,821)
(99,381)
Taxation credit for the year
(131,821)
(99,381)
Tax losses of £1,482,514 (2024: £1,482,514) are available to carry forward to use against future profits. Due to uncertainty over the level of losses that the company will be able to utilise, deferred tax has not been provided for.
10
Intangible fixed assets
Patents
Development Costs
Total
£
£
£
Cost
At 1 April 2024
78,076
348,566
426,642
Additions
6,711
6,711
At 31 March 2025
84,787
348,566
433,353
Amortisation and impairment
At 1 April 2024
55,335
348,566
403,901
Amortisation charged for the year
2,640
2,640
At 31 March 2025
57,975
348,566
406,541
Carrying amount
At 31 March 2025
26,812
26,812
At 31 March 2024
22,741
22,741
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 23 -
11
Property, plant and equipment
Land and buildings Short leasehold
Plant and machinery
Fixtures, fittings & equipment
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 April 2024
1,439,905
3,549,813
920,972
92,793
6,003,483
Additions
115,360
87,410
202,770
At 31 March 2025
1,439,905
3,665,173
1,008,382
92,793
6,206,253
Depreciation and impairment
At 1 April 2024
1,434,905
2,580,943
791,948
78,918
4,886,714
Depreciation charged in the year
5,000
208,679
50,413
4,579
268,671
At 31 March 2025
1,439,905
2,789,622
842,361
83,497
5,155,385
Carrying amount
At 31 March 2025
-
875,551
166,021
9,296
1,050,868
At 31 March 2024
5,000
968,870
129,024
13,875
1,116,769
The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts.
2025
2024
£
£
Plant and machinery
810,500
898,765
Computer equipment
65,051
70,105
875,551
968,870
12
Financial instruments
2025
2024
£
£
Carrying amount of financial assets
Debt instruments measured at amortised cost
4,515,827
4,116,506
Instruments measured at fair value through profit or loss
38,974
69,245
Carrying amount of financial liabilities
Measured at amortised cost
5,994,997
6,840,447
The company uses derivative financial instruments to hedge against adverse movements in foreign exchange. At the end of the year the company had forward foreign exchange contracts in place. These contracts are not traded in active markets. They have been measured at fair value based on the forward exchange rate at the maturity of the contract and the spot rate at the year end.
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 24 -
13
Inventories
2025
2024
£
£
Raw materials and consumables
1,111,050
1,726,493
Work in progress
2,547,499
3,188,590
3,658,549
4,915,083
14
Trade and other receivables
2025
2024
Amounts falling due within one year:
£
£
Trade receivables
4,393,364
4,004,895
Corporation tax recoverable
131,821
99,381
Derivative financial instruments
38,974
69,245
Other receivables
122,463
111,611
Prepayments and accrued income
9,794,239
7,950,844
14,480,861
12,235,976
Trade receivables disclosed above are measured at amortised cost.
15
Current liabilities
Restated
2025
2024
Notes
£
£
Borrowings
17
2,610,781
2,742,960
Obligations under finance leases
18
235,668
297,995
Payments received on account
275,749
864,279
Trade payables
2,852,129
2,914,543
Other taxation and social security
204,172
108
Other payables
20,670
20,670
Accruals and deferred income
836,421
685,636
7,035,590
7,526,191
16
Non-current liabilities
2025
2024
Notes
£
£
Bank loans and overdrafts
17
180,000
540,000
Obligations under finance leases
18
261,791
313,447
441,791
853,447
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 25 -
17
Borrowings
Restated
2025
2024
£
£
Bank loans
2,146,544
2,663,190
Directors' loans
644,237
619,770
2,790,781
3,282,960
Payable within one year
2,610,781
2,742,960
Payable after one year
180,000
540,000
In 2021, the company received a Coronavirus Business Interruption Loan of £1,800,000. The loan is repayable by 31 July 2026 and interest is being charged at 3.8%. Capital repayments commenced in October 2021. The company also has a working capital facility in place of £2,500,000 on which interest being charged at LIBOR+3%. At the end of the year, £1,606,544 of this facility was in use. The working capital facility is secured by a debenture dated 13 September 2017 containing a fixed and floating charge over the assets of the company and contains a negative pledge.
The Company operates a multi-currency cash management facility under which account balances are managed on a net basis. Certain accounts may show overdrawn positions; however, these do not represent standalone overdrafts and form part of the pooled cash arrangement. Accordingly, the net balance has been presented within cash and cash equivalents, as this reflects the substance of the facility.
The prior year comparative figures have been restated to reflect this presentation consistently.
18
Finance lease obligations
2025
2024
Future minimum lease payments due under finance leases:
£
£
Within one year
235,667
297,995
In two to five years
261,792
313,447
497,459
611,442
Finance lease payments represent rentals payable by the company for certain items of plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. Lease terms are between three and five years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 26 -
19
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
596,336
505,885
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
On 31 March 2025 the amount payable to the scheme was £106,965 (2024: £99,435).
20
Share capital
2025
2024
Ordinary share capital
£
£
Issued and fully paid
316 Ordinary shares of £100 each
31,600
31,600
The company has only one class of ordinary shares which carry no right to fixed income.
21
Share premium account
The share premium accounts represents the premium arising on the issue of shares net of issues costs.
22
Retained earnings
The retained earnings account represents cumulative profits and losses net of dividends and other adjustments.
23
Financial commitments, guarantees and contingent liabilities
The company is, from time to time, required to provide guarantees in accordance with the terms of contracts entered into in its normal course of business. The amount of these guarantees as at 31 March 2025 was £nil(2024: £29,372).
The company had provided the following outstanding guarantees at 31 March 2025:
Limited Guarantee given by export credits departments for CHF 519,150
Limited Guarantee given by export credits departments for GBP 40,500
Limited Guarantee given by export credits departments for EUR 1,077,350
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 27 -
24
Operating lease commitments
Lessee
Operating lease payments represent rentals payable by the company for certain items of equipment. Operating leases are negotiated for average terms of 5 years.
At 31 March 2025 the company was committed the following payments under non cancellable operating leases in the year to 31 March 2025.
2025
2024
£
£
Within one year
1,172,655
214,783
Between two and five years
879,491
2,052,146
214,783
The operating leases represent leases of properties from third parties. The leases are negotiated over terms of 10 years with break clauses after 5 years. All leases include a provision for five-yearly upward rent reviews according to prevailing market conditions.
25
Capital commitments
Amounts contracted for but not provided in the financial statements:
2025
2024
£
£
Acquisition of property, plant and equipment
14,090
54,215
26
Related party transactions
Remuneration of key management personnel
The remuneration of key management personnel is as follows.
2025
2024
£
£
Aggregate compensation
584,071
547,869
Other information
During the year the company accrued interest of £40,000 (2024: £40,000) on a loan from Dr J Good, a director of the company. At the year end the accrued interest was £43,967 (2024: £19,499) outstanding to Dr J Good.
At the end of the year, loan capital of £600,270 (2024: £600,270) was due to Dr J Good.
27
Ultimate controlling party
The ultimate controlling party is Dr J Good, a director of the company.
CRYOGENIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 28 -
28
Cash generated from/(absorbed by) operations
2025
2024
£
£
Profit after taxation
1,303,940
1,296,202
Adjustments for:
Taxation credited
(131,821)
(99,381)
Finance costs
250,493
293,271
Amortisation and impairment of intangible assets
2,640
Depreciation and impairment of property, plant and equipment
268,671
388,900
Other gains and losses
(38,974)
(41,776)
Movements in working capital:
Decrease/(increase) in inventories
1,256,534
(28,617)
Increase in trade and other receivables
(2,242,716)
(2,428,620)
(Decrease)/increase in trade and other payables
(271,628)
433,964
Cash generated from/(absorbed by) operations
397,139
(186,057)
29
Analysis of changes in net debt
1 April 2024
Cash flows
31 March 2025
£
£
£
Cash at bank and in hand
626,263
(524,838)
101,425
Borrowings excluding overdrafts
(2,663,190)
516,646
(2,146,544)
Lease liabilities
(611,442)
113,983
(497,459)
(2,648,369)
105,791
(2,542,578)
2025-03-312024-04-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.300No description of principal activityDr J GoodDr R MitchellMs Z OmarMr M OwczarkowskiJulie McKay026595432024-04-012025-03-3102659543bus:Director12024-04-012025-03-3102659543bus:Director22024-04-012025-03-3102659543bus:Director32024-04-012025-03-3102659543bus:Director42024-04-012025-03-3102659543bus:CompanySecretary12024-04-012025-03-3102659543bus:RegisteredOffice2024-04-012025-03-3102659543bus:Agent12024-04-012025-03-31026595432025-03-31026595432023-04-012024-03-3102659543core:RetainedEarningsAccumulatedLosses2023-04-012024-03-3102659543core:RetainedEarningsAccumulatedLosses2024-04-012025-03-3102659543core:OtherResidualIntangibleAssets2025-03-3102659543core:OtherResidualIntangibleAssets2024-03-3102659543core:PatentsTrademarksLicencesConcessionsSimilar2025-03-3102659543core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-03-3102659543core:PatentsTrademarksLicencesConcessionsSimilar2024-03-3102659543core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-03-31026595432024-03-3102659543core:PlantMachinery2025-03-3102659543core:FurnitureFittings2025-03-3102659543core:MotorVehicles2025-03-3102659543core:LandBuildings2024-03-3102659543core:PlantMachinery2024-03-3102659543core:FurnitureFittings2024-03-3102659543core:MotorVehicles2024-03-3102659543core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3102659543core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3102659543core:Non-currentFinancialInstrumentscore:AfterOneYear2025-03-3102659543core:Non-currentFinancialInstrumentscore:AfterOneYear2024-03-3102659543core:Non-currentFinancialInstruments2025-03-3102659543core:Non-currentFinancialInstruments2024-03-3102659543core:ShareCapital2025-03-3102659543core:ShareCapital2024-03-3102659543core:SharePremium2025-03-3102659543core:SharePremium2024-03-3102659543core:RetainedEarningsAccumulatedLosses2025-03-3102659543core:RetainedEarningsAccumulatedLosses2024-03-3102659543core:ShareCapital2023-03-3102659543core:SharePremium2023-03-3102659543core:RetainedEarningsAccumulatedLosses2023-03-3102659543core:ShareCapitalOrdinaryShareClass12025-03-3102659543core:ShareCapitalOrdinaryShareClass12024-03-310265954312024-04-012025-03-310265954312023-04-012024-03-310265954322024-04-012025-03-310265954322023-04-012024-03-31026595432024-03-31026595432023-03-3102659543core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3102659543core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-04-012025-03-3102659543core:PlantMachinery2024-04-012025-03-3102659543core:FurnitureFittings2024-04-012025-03-3102659543core:ComputerEquipment2024-04-012025-03-3102659543core:MotorVehicles2024-04-012025-03-3102659543core:UKTax2024-04-012025-03-3102659543core:UKTax2023-04-012024-03-3102659543core:PatentsTrademarksLicencesConcessionsSimilar2024-03-3102659543core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-03-3102659543core:PatentsTrademarksLicencesConcessionsSimilarcore:ExternallyAcquiredIntangibleAssets2024-04-012025-03-3102659543core:DevelopmentCostsCapitalisedDevelopmentExpenditurecore:ExternallyAcquiredIntangibleAssets2024-04-012025-03-3102659543core:ExternallyAcquiredIntangibleAssets2024-04-012025-03-3102659543core:PatentsTrademarksLicencesConcessionsSimilar2024-04-012025-03-3102659543core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-04-012025-03-3102659543core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-03-3102659543core:PlantMachinery2024-03-3102659543core:FurnitureFittings2024-03-3102659543core:MotorVehicles2024-03-3102659543core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-03-3102659543core:ComputerEquipment2025-03-3102659543core:ComputerEquipment2024-03-3102659543core:FinancialAssetsDesignatedFairValueThroughProfitOrLoss2025-03-3102659543core:FinancialAssetsDesignatedFairValueThroughProfitOrLoss2024-03-3102659543core:CurrentFinancialInstruments2025-03-3102659543core:CurrentFinancialInstruments2024-03-3102659543core:WithinOneYear2025-03-3102659543core:WithinOneYear2024-03-3102659543core:BetweenTwoFiveYears2025-03-3102659543core:BetweenTwoFiveYears2024-03-3102659543bus:PrivateLimitedCompanyLtd2024-04-012025-03-3102659543bus:FRS1022024-04-012025-03-3102659543bus:Audited2024-04-012025-03-3102659543bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP